Feed Preview

Microbiome & Cancer

Microbiome & Cancer diagram by Kateryna Kon, Shutterstock
Kateryna Kon, Shutterstock

The human microbiome has been implicated in altering cancer susceptibility and therapeutic responses to anti-cancer agents. Here is the latest research on the influence of the microbiome and cancer.

Top 20 most recent papers
The New England Journal of Medicine

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

The New England Journal of MedicineFebruary 27, 2020
Jonathan U PeledMarcel R M van den Brink
Genome Biology

Author Correction: Interaction between the microbiome and TP53 in human lung cancer

Genome BiologyFebruary 22, 2020
K Leigh GreathouseCurtis C Harris
PLoS Pathogens

Cervicovaginal microbiome and natural history of HPV in a longitudinal study

PLoS PathogensMarch 28, 2020
Mykhaylo UsykCosta Rica HPV Vaccine Trial (CVT) Group

mbImpute: an accurate and robust imputation method for microbiome data

bioRxivMarch 8, 2020
Ruochen JiangJingyi Jessica Li
Trends in Cancer

The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View

Trends in CancerFebruary 27, 2020
Joao B XavierJennifer A Wargo

Predictable modulation of cancer treatment outcomes by the gut microbiota

MicrobiomeMarch 7, 2020
Yoshitaro HeshikiGianni Panagiotou
NPJ Biofilms and Microbiomes

Metaproteomics characterizes human gut microbiome function in colorectal cancer

NPJ Biofilms and MicrobiomesMarch 27, 2020
Shuping LongLiang Qiao
Frontiers in Oncology

Opportunities and Challenges of the Human Microbiome in Ovarian Cancer

Frontiers in OncologyMarch 6, 2020
Huiyan ChengHuanfa Yi
Frontiers in Cellular and Infection Microbiology

The Oral Microbiota May Have Influence on Oral Cancer

Frontiers in Cellular and Infection MicrobiologyFebruary 5, 2020
Ling ZhangChen Ping Zhang
Journal of Gastroenterology and Hepatology

Intestinal microbiota and its association with colon cancer and red/processed meat consumption

Journal of Gastroenterology and HepatologyMarch 22, 2020
Nadine Abu-GhazalehVinod Gopalan
Mucosal Immunology

Host responses to mucosal biofilms in the lung and gut

Mucosal ImmunologyMarch 1, 2020
Jada C DomingueCynthia Sears
Investigative and Clinical Urology

The human gastrointestinal microbiota and prostate cancer development and treatment

Investigative and Clinical UrologyFebruary 15, 2020
Sybil ShaVladimir Mouraviev
Microbiology and Molecular Biology Reviews : MMBR

Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer

Microbiology and Molecular Biology Reviews : MMBRMarch 6, 2020
Matteo BelloneSamuel Huber
Biomedit︠s︡inskai︠a︡ khimii︠a︡

Intestinal microbiom modulates the response to antitumor immunotherapy

Biomedit︠s︡inskai︠a︡ khimii︠a︡March 3, 2020
E I OlekhnovichE N Ilina

See more papers from this feed

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

© 2020 Meta ULC. All rights reserved